N/A Completed N=532 Randomized Triple-blind Supportive Care

A Comparative Trial of Improving Care for Underserved Asian Americans Infected With HBV

Hepatitis B

Source: ClinicalTrials.gov NCT02421666 ↗

Enrolled (actual)

532

Serious AEs

0.0%

Results posted

Oct 2020

Primary outcomePrimary: Change of the Rates of Participants Who Adherent to Recommended Clinical Care for the Monitoring of Chronic HBV Infection — 200; 113; 225; 140 Participants

Summary

Asian Americans have the highest incidence, mortality and prevalence rates of hepatocellular carcinoma (HCC) among all U.S. racial and ethnic groups. The goal of this study is to investigate the efficacy of a Patient Navigator-led mobile phone text Messaging Intervention (PNMI) in improving hepatitis B follow-up care management for Asian Americans with chronic hepatitis B infection through a randomized controlled trial.

Outcome Measures

Outcome	Result	p-value
PRIMARY Change of the Rates of Participants Who Adherent to Recommended Clinical Care for the Monitoring of Chronic HBV Infection	200; 113; 225; 140; 137; 62	—

Eligibility Criteria

Inclusion Criteria

self-identified Chinese, Korean and Vietnamese ethnicity
age 18 and above
accessible by telephone with text message feature
presence in the same geographic study area for a period of one year
not enrolled in any chronic HBV adherence management intervention
medically diagnosed chronic HBV infection with positive for hepatitis B surface antigen (HBsAg) for more than six months, and
Never or non compliant with HBV monitoring guidelines.

Exclusion Criteria

Patients were excluded from the study for the following conditions:

diagnosed with cirrhosis, hepatocellular carcinoma, liver failure and liver cancer
concurrent hepatitis C infection, and
concurrent HIV infection

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02421666). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.